The formation of amyloid-like protein structures has recently emerged as a feature in signal transduction, particularly in innate immunity. These structures appear to depend on defined domains for their formation but likely also require dedicated ways to terminate signalling. We, here, define the innate immunity protein/Toll-like receptor adaptor TIR-domain-containing adapter-inducing interferon-b (TRIF) as a novel platform of fibril formation and probe signal initiation through TRIF as well as its termination in Toll-like receptor 3 (TLR3)-stimulated melanoma cells. A main signalling pathway triggered by TLR3 caused apoptosis, which was controlled by inhibitor of apoptosis proteins and was dependent on RIPK1 and independent of TNF. Using correlative electron/fluorescence microscopy, we visualised fibrillar structures formed through both Toll/interleukin-1 receptor and RIP homotypic interacting motif regions of TRIF. We provide evidence that these fibrillary structures are active signalling platforms whose activity is terminated by autophagy. TRIF-signalling enhanced autophagy, and fibrillary structures were partly contained within autophagosomes. Inhibition of autophagy increased levels of pro-apoptotic TRIF complexes, leading to the accumulation of active caspase-8 and enhanced apoptosis while stimulation of autophagy reduced TRIF-dependent death. We conclude that pro-death signals through TRIF are regulated by autophagy and propose that pro-apoptotic signalling through TRIF/RIPK1/caspase-8 occurs in fibrillary platforms.
Introduction
Toll/interleukin-1 receptor (TIR)-domain-containing adapter-inducing interferon-b (TRIF) [also known as Toll-like receptor adaptor molecule 1 (TICAM1)] is an adaptor protein involved in Toll-like receptor (TLR) signalling.
While most TLRs signal TRIF independently through MyD88, TLR4 signals via both MYD88 and TRIF, and TLR3 uses TRIF exclusively for recruiting downstream signalling proteins [1, 2] . TRIF signals are important for activation of professional innate immune cells such as macrophages, where
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they contribute to cell maturation and cytokine production. TLR3 and TRIF are, however, also expressed by numerous other cell types including tumour cells where they probably signal especially in NF-jB activation and in cell death. TRIF contains a RIP homo interacting motif (RHIM) that is able to recruit the receptor interacting protein kinases (RIPK) RIPK1 and RIPK3 [3] . RIPK1 and RIPK3 interact through their respective RHIMs and are thought to form an amyloidal fibril via this interaction [1] [2] [3] [4] . TRIF activation can lead to cell death by activation of the RIP kinases and/or caspase-8. RIPK1 contains a death domain (DD), which is able to recruit FADD and subsequently caspase-8, which can lead to caspase-8-dependent cell death [3] .
This pathway is similar in many respects to the recruitment and activation of caspase-8 at death receptors such as TNFR1, TRAIL and CD95/Fas. As with death receptor signalling, in many cell types, TLR3 activation can induce both apoptosis and necroptosis. Necroptosis is a regulated, nonapoptotic form of cell death that is caspase-independent but dependent on the kinase activity of RIPK 1 and/or 3 (reviewed in Ref. [5] ). Under normal signalling conditions, recruitment of RIP kinases to caspase-8 containing complexes or vice versa results in the caspase-8 dependent cleavage of the RIPK, essentially inactivating them and blocking necroptosis [6] . When caspase-8 activity is blocked by caspase inhibitors such as Z-VAD-FMK (ZVAD) or Q-VD-OPH (QVD), the RIP kinases are not cleaved and necroptosis can be initiated.
Activation of TNFR1 and signals mediated by TRIF may be skewed to promote cell death, both apoptosis and necroptosis, by inhibition of the cellular inhibitor of apoptosis protein (cIAP) family. cIAPs, namely cIAP1, cIAP2 and XIAP, are ubiquitin ligases that regulate the signals originating from TNF family receptors, TLRs, NOD receptors and likely others. A class of new therapeutic drugs (also known as Smacmimetics) acts as IAP antagonists and lead to increased activation of caspase-8 in response to receptors able to recruit it (such as TNFR1 and also TRIF), as well as an increased recruitment of RIP kinases [7, 8] . With these properties, the drugs thus show promise as therapeutics that can sensitise cancers to death induced by chemotherapeutics but also endogenous cell death pathways. Some melanoma cells for instance are sensitive to combination treatment with inhibitor of apoptosis protein (IAP) antagonists and the TLR3 ligand poly I:C (pI:C) [9] . This treatment triggers a TRIF-dependent apoptotic cell death that requires caspase-8 activity.
A recent development in models of signalling cascades has been the observation of very large assemblies of signalling scaffolds that can propagate signal transduction. These scaffolds are often fibrillar and/or prion like in nature, and to date, they have been described for proteins in a number of signalling pathways including both RIPK1 and 3 during TNF signalling [4] , the adapter of RIG like helicases, MAVS [10] , the BCL10.CARMA1.MALT1 complex during T-cell receptor signalling [11] , and also the inflammasome component ASC [12, 13] .
Thus, the formation of big scaffolds is likely a common way of generating signalling platforms. These platforms may be expected to have high activity that will have to be controlled to avoid undesired side effects such as hyperinflammation and cell death. It is, therefore, necessary that they can be silenced or disassembled effectively. Given their size and stability, it seems most likely that they will have to be moved into a dedicated degradation pathway. One possible mechanism is here autophagy, which is known to be able to target large aggregated protein complexes for degradation [14] .
Indeed, it has been reported that caspase-8 can be ubiquitylated and recruited to aggresomes [15] . Aggresomes are formed by recruitment of ubiquitylated proteins to autophagy receptors such as p62/SQSTM1 [14] . p62/SQSTM1 aggresomes are targeted to autophagosomes, which engulf the aggresome and transport it to lysosomes for degradation. In this way, aggresomes appear to act as both signalling platforms for regulating activity of signalling complexes, and then their subsequent degradation.
As discussed above, TRIF contains a RHIM that may, as does the RHIM in RIPK1 and -3, initiate the formation of a large signalling platform. In this study, we have explored this possibility and tested what role this may have in the activation of caspase-8 and of RIP kinases. We then tested the hypothesis that autophagy may be required for the clearance of TRIF-containing platforms and that its inhibition may be able to sensitise melanoma cells further to killing by TLR3 stimulation in the presence of IAP antagonists.
Results
Autophagy inhibition sensitises melanoma cells to apoptosis induced by IAP antagonist plus poly I:C We have previously reported that the monomeric IAP antagonist LBW242 (LBW) and pI:C treatment can kill some melanoma cells [9] . This killing was shown to be caspase-8 dependent cell death. Requirements for caspase-8 [16] [17] [18] , RIPK1 [17, 18] and independence to TNF signalling [16, [18] [19] [20] have also been shown in various other normal and cancer cells.
It has been reported that autophagy is induced in macrophages in response to TLR4-signals in a TRIFdependent fashion [21] . It has also been reported that TRIF can be degraded through autophagy by interaction with the autophagy receptor protein NDP52, but this is only apparent in the absence of the deubiquitinating enzyme A20, which removes ubiquitin chains from TRIF [22] . If autophagy is required for removal of assembled TRIF complexes in melanoma cells, it might be possible that inhibiting this process could further sensitise melanomas to killing by the TLR3 pathway.
We found that autophagy was also induced in melanoma cells by TLR3 stimulation. 1205LU SBCL2 and WM1158 melanoma cells were treated with pI:C in the presence or absence of Thapsigargin, which blocks autophagic flux by inhibiting fusion of autophagosomes and lysosomes [23] . Levels of LC3B-II as a marker of autophagy induction were analysed by western blotting. Thapsigargin alone causes a build-up of LC3-II (Fig. 1A ). An induction of autophagy should show a further increase in the levels of LC3-II on top of that induced by thapsigargin as shown by the positive control Rapamycin (Fig. 1A) . We found, with variable kinetics, an increase in LC3B-II in the presence of thapsigargin after treatment with pI:C indicating the activation of autophagy in response to TLR3/TRIF signalling in melanoma cells (Fig. 1A) . In addition, Wm1158 melanoma cells were infected with a lentivirus expressing mCherry-gfp-LC3, and these cells were then treated with pI:C. Images were taken over time to analyse the formation of gfp+ autophagosomes in response to TLR3 stimulation as a measure of autophagy activity. There was a time-dependent increase in the number of GFP+ autophagosomes in treated cells (Fig. 1B) , again indicating an induction of autophagy in response to TRL3 activation.
Autophagic degradation of specific proteins occurs through recruitment to autophagic receptors that bind ubiquitylated proteins and recruit LC3-II to trigger engulfment by autophagosomes. P62/SQSTM1, a wellcharacterised autophagy cargo receptor, has been reported to interact with RIPK1 [24] , caspase-8 [15] and RIPK3 [25] , all known to be recruited to TRIF and to be involved in the initiation of TLR3-induced cell death, making p62 a likely target for TRIF complex degradation. To test for potential interaction between TRIF and p62, we used proximity ligation assay (PLA) to assess if endogenous TRIF interacts with P62 during TLR3 signalling. When one of the very pI:C-sensitive melanoma cell lines (WM1158) was used, addition of pI: C triggered a time-dependent increase in PLA signal relative to untreated controls showing increased recruitment of TRIF to p62 (Fig. 1C) .
To determine if TRIF is directly degraded by autophagy in melanomas, WM1158 cells were treated with pI:C in the presence of cycloheximide to block production of newly synthesised TRIF together with thapsigargin, shown in Fig. 1A to block autophagic flux, or LY294002 (LY), a PI3K inhibitor that inhibits the induction of autophagy [26] . There was a near complete loss of TRIF after 4 h in control cells not treated with thapsigargin, but in treated cells, there was a substantial repression of TRIF loss. Treatment with LY, which blocks the formation of new autophagosomes, was also able to block degradation of TRIF after 4 h to a similar extent as thapsigargin. Together these data show that by inhibiting autophagy at two separate points results in stabilisation of TRIF after pI:C treatment (Fig. 1D) . Autophagy, therefore, appears to be an important mechanism in the regulation of TRIF turnover upon stimulation through TLR3.
Given TRIF is degraded by autophagy, inhibiting autophagy may prolong and/or enhance TRIF signals due to TRIF complexes prolonged lifespan. To test this, IL-8 production in 1205LU cells expressing either a control shRNA or an shRNA against Atg5 was tested by ELISA. Atg5 is required for formation of LC3-II and thus formation of autophagosomes and its loss blocks autophagy. Several other melanoma cell lines were also infected with lentivirus expressing ATG5 shRNA, but these failed to proliferate initially and the majority of cells that were selected maintained ATG5 expression and were thus not used hinting that basal autophagy may also be an important factor in survival of a number of melanoma cells. 1205LU cells expressing a control shRNA showed robust IL-8 secretion; however, there is a clear increase in the amount of IL-8 produced in the Atg5shRNA expressing cells, supporting an enhancement of signalling in the absence of autophagy ( Fig. 2A) .
As we have reported previously, in melanoma cells, TRIF activation through pI:C can lead to caspase-8 activation and cell death. We, therefore, next blocked autophagy and tested for pro-cell death signalling through TRIF. We first treated five human melanoma cells with pI:C together with LY which could block TRIF degradation in Fig. 1 . In all melanoma cell lines tested, co-treatment with LY, pI:C and LBW resulted in an increase in cell death after 24 h (Fig. 2B) . To confirm that the sensitisation is specific to autophagy inhibition by LY, 1205LU cells expressing shRNA targeting ATG5 were tested for killing by pI:C and LBW. Atg5 shRNA expressing cells were sensitised to pI:C and LBW treatment relative to the control shRNA expressing cell line, showing that autophagy inhibition by shRNA can phenocopy LY treatment (Fig. 2C) .
A role for autophagy in silencing TRIF signalling would also predict that induction of autophagy may suppress TRIF-mediated killing since TRIF complexes would be cleared more rapidly. The highly sensitive cell lines, WM35 and SBCL2, were treated with rapamycin to induce autophagy prior to pI:C+LBW treatment followed by analysis of cell survival. As predicted, rapamycin treatment partially protected from pI:C and pI:C+LBW induced death (Fig. 2D) , showing the opposite effect of autophagy inhibition. The inhibition was incomplete, but this effect appears to be consistent with a situation where formation of the death-inducing complexes still occurs but their removal is slowed down. Together these data indicate that autophagy counterregulates TRIF-dependent apoptosis and cytokine production in melanoma cells.
Autophagy inhibition enhances caspase-8 activation in melanoma cells
We hypothesised that increased apoptosis when autophagy is inhibited was due to delayed clearance of for SBCL2 for 24 h. Survival was measured by propidium iodide exclusion. Error bars indicate the SEM of at least three independent experiments for each of the panels in this figure.
for various times and the level of active caspase-8 was followed. Little to no active caspase-8 was seen with pI:C treatment alone, whereas addition of LBW resulted in the appearance of active caspase-8 within 4 h. Treatment with pI:C/LBW/LY, however, resulted in substantially enhanced levels of active caspase-8 after 4 and 8 h (Fig. 3A) . Inhibition of autophagy by ATG5 shRNA also resulted in enhanced levels of active caspase-8 in cells treated either with pI:C or with pI:C/LBW242 (Fig. 3B ), suggesting that TRIF signalling complexes containing active caspase-8 accumulate in the absence of autophagy. It was also observed that PI3K inhibition with LY resulted in reduced cFLIP levels (Fig. 3A,B) . Such a loss has been previously reported in some cancer cell types [27, 28] . cFLIP is an endogenous inhibitor of caspase-8 and a reduction in its levels may also account for increases in active caspase-8 levels. However, there was also a clear increase in the amount of cleaved caspase-8 in cells where autophagy was inhibited not by LY treatment but by ATG5 shRNA upon treatment with pI:C and LBW (Fig. 3B ) while cFLIP levels were not affected (Fig. 3B) . This was further enhanced by treatment with LY showing that the effect of LY may be both due to inhibition of autophagy and also reduction of cFLIP levels. Of note, pI:C and LY treatment (without LBW) also caused a decrease in cFLIP levels in the 1205LU cell line (Fig. 3B ), but this treatment was insufficient to enhance cell death (Fig. 2B) . The effect of LY treatment on cFLIP levels alone is, therefore, unlikely to be the only cause of sensitisation of melanoma cells to killing in response to treatment with pI:C/LBW/LY but may also synergise with autophagy inhibition. The activation of caspase-3 was also determined under autophagy inhibition by LY and Atg5 shRNA expression. Caspase-3 activation mirrors the activation of caspase-8 that is seen in the 1205LU cell line, showing that this level of caspase-8 activation is leading to the activation of caspase-3 (Fig. 3C) . Again it can be seen, however, that there is a synergy between LY and LBW treatment with there being a significant increase in the activation of caspase-3 when both are used. This effect is more pronounced in the Atg5 shRNA expressing cells, which again may suggest a synergy between loss of autophagy and PI3K inhibition leading to cFLIP reduction.
Caspase-8 and 3 activation ( Figure 3A -C) and blockage by QVD (Fig. 2B ) suggest that the cell death induced is apoptosis. Apoptosis induced by caspase-8 may occur via both a direct route (type I) with caspase-8 cleaving caspase-3 and an indirect route via mitochondrial apoptosis due to caspase-8 cleavage of BID (type II). To test if the melanomas die via a type I or type II pathway, cells were infected with a lentivirus overexpressing BCL-X L . Depending on the cell type, either type I or type II pathways were active. Bcl-X L overexpression could only protect partially in SBCL2 cells, not at all in WM1158 cells but completely in 1205LUs (Fig. 3D ). These data indicate that sensitisation due to autophagy inhibition is likely to act at the level of caspase-8 activation as both cells dying via a type I pathway (SBCL2 and WM1158) and cells dying via the mitochondrial pathway (1205LU) are sensitised.
Curiously, when levels of RIPK3 were examined in the melanomas, no expression was detectable in any of the cell lines tested (Fig. 3E) , explaining the lack of necroptosis in melanoma cells treated with pI:C, IAP antagonists and caspase inhibitors and suggesting that RIPK3 expression may be detrimental for cancer progression; this has recently been suggested also in other cancer cells [29] [30] [31] .
TRIF recruits active caspase-8 into detergentinsoluble fractions
An important question is why TRIF needs to be targeted by autophagy for degradation as opposed to proteasomal degradation. As discussed, killing by TLR3 and its signalling adaptor TRIF requires interaction with RIPK1 and/or also RIPK3 via the RHIM [3, 32] . RIPK1 and 3 can form amyloid fibrils through their RHIM interactions during signalling [4] (although this has largely so far been shown with recombinant proteins or complexes isolated from cells transfected with RIPK-expression constructs) raised the question of whether TRIF may also be recruited into such complexes. Amyloid fibrils such as those formed by RIPK1 and RIPK3 are typically very large and extremely stable. Such large and stable structures are likely difficult substrates for proteasomes, which must unfold their substrates in order for degradation to occur, making them likely targets of autophagic clearance. Large fibrillar signalling complexes are often insoluble in nonionic detergents such as Triton X-100. If TRIF also formed such large signalling platforms, this may be detectable by testing for TRIF in detergentinsoluble fractions along with the RIP kinases after TRIF is activated. Endogenous TRIF proved difficult to detect by western blotting from melanoma cells. MEFs were, therefore, generated that carried TRIF under an inducible promoter in order to examine if active TRIF complexes are contained in detergent soluble or insoluble fractions. TRIF is known to auto-activate, recruiting RIPK1 and caspase-8 when overexpressed [3] . TRIF was induced, and cells were lysed with Triton X-100 and split into soluble and insoluble fractions.
TRIF induction led to a substantial translocation of TRIF to a Triton X-100 insoluble fraction (Fig. 4A) . This was not significantly enhanced by LBW treatment, however, suggesting that IAP activity, despite being required for survival signals, does not affect the formation of auto-activated TRIF complexes. Combined induction of TRIF and treatment with LBW triggered recruitment of active, cleaved caspase-8 to the insoluble fraction. Full processing of caspase-8 in this fraction was blocked by the caspase-inhibitor QVD while intermediate processing was not blocked (Fig. 4A) . In the soluble fraction, there was also an increase in cleaved caspase-8, both fully cleaved (p18) and the product of intermediate cleavage (p41/43). However, this was not blocked by QVD. In the insoluble fraction, both cleaved RIPK3 and RIPK1 could also be detected upon TRIF induction in combination with LBW (Fig. 4A) . Generation of the cleaved RIPK1/RIPK3 fragments could be blocked by caspase inhibition with QVD, suggesting that RIPK1 and RIPK3 cleavage fragments were very likely generated by caspase-8 as previously reported [6, 33] , and this cleavage is likely to occur in the insoluble fraction. There was relatively little cleavage of RIPK1 or RIPK3 in the soluble fraction. These results are consistent with active TRIF signalling complexes containing cleaved caspase-8, RIPK1 and RIPK3 being concentrated in the insoluble fraction and suggest that like the RIP kinases TRIF may form fibrillar complexes.
A technique to test for the formation of large protein aggregates is SDD-AGE, which has been used for analysing amyloid forming proteins such as MAVS fibrils [10, 34] . To test whether the translocation of TRIF to insoluble fractions represented formation of very large TRIF complexes, lysates from TRIF inducible MEFs were subjected to SDD-AGE. Upon TRIF induction, no TRIF oligomers were detectable (Fig. 4B) . Co-addition of LBW did not result in the formation of detectable TRIF oligomers on SDD-AGE in wild-type cells; however, addition of caspase inhibitors, ZVAD or QVD, did reveal TRIF oligomers, which appear to smear into the gel (Fig. 4B) . This may indicate that capase-8 can cleave and help prevent oligomerization of TRIF complexes. However, detection of any signal was also dependent on denaturing of proteins on the membranes prior to antibody decoration, hinting that the N-terminal FLAG epitope on TRIF may be hidden, and that in caspase inhibitor-treated cells, it is more freely exposed. Caspase-8 À/À MEFs were also tested with inducible TRIF, and perhaps due to both increased TRIF expression as a result of their insensitivity to its killing activity and the potential alterations in TRIF conformation when caspase-8 activity is blocked/absent, large smears of TRIF could immediately be detected upon induction without further treatments (Fig. 4C) . These results suggest that TRIF can form very large structures that may reflect protein fibrils.
TRIF forms filamentous structures through its RHIM and TIR regions
Fibril formation has been associated with function in a number of signalling adaptors. In particular, RIPK3 fibril formation via the RHIM region has been linked to necroptotic signalling [4] . Mutation of this region prevented formation of fibrils and also blocks necroptosis suggesting that both fibril formation and function are linked. The formation of MAVS fibrils has been linked to IFN I-signalling [10] . TRIF contains at least two regions for both homooligomerization and hetero-oligomerization, namely the TIR domain and the RIP homotypic interaction motif (RHIM). The TIR domain is responsible for interaction with TLR3, while the RHIM is responsible for interaction with the RIP kinases through their respective RHIMs. It has been reported that TRIF can also homodimerise through these regions and mutation of either region changes the signal elicited by TRIF [35] .
In order to determine the effect that oligomerization defects would have on TRIF complexes, TRIF was mutated to have either a P436H mutation in the TIR (blocking homodimerization, [35] ) or a VQLG (aa 687-691) -AAAA mutation in the RHIM region (ΔRHIM). The DRHIM mutation should, based on the same mutation in the RHIM of RIPK3, block heterodimerization with RIP kinases and homodimerization with itself.
As SDD-AGE cannot determine the nature of the detected complexes, TRIF and the above-described oligomerisaton mutants were visualised within cells by electron microscopy (EM) using the miniSOG tag [36] . MiniSOG is a small tag designed for correlated light and EM and can be used to trigger aggregation of diaminobenzidine (DAB) in the presence of blue light. miniSOG was fused to the C-terminus of TRIF, and HeLa cells were transiently transfected with expression plasmids driving TRIF-miniSOG and the respective mutants. To avoid cell death, the cells were co-treated with QVD. Of note, the particular HeLa cell line used does not express RIPK3 (data not shown), avoiding activation of necroptosis.
A fluorescent signal was detectable in transfected cells, showing punctate structures for wild-type TRIF (Fig. 5A) . Expression of the ΔRHIM version of TRIF led to mostly elongated structures with punctate structures also visible, while the P436H mutant had predominantly punctate structures, similar to the wild type (Fig. 5A ). This light-microscopic phenotype has been reported previously for TRIF [35] . The double mutant showed no obvious green fluorescent structures, suggesting it failed to oligomerise (Fig. 5A) .
To determine if TRIF was colocalising with RIPK1, HeLa cells were also co-transfected with a tagRFP657-RIPK1 expressing plasmid, and localisation of RIPK1 and TRIF was analysed. tagRFP657-RIPK1 formed punctate patterns when expressed alone, indicating that it can also auto-activate (Fig. 5B) . Wild-type TRIF-miniSOG co-localised with tagRFP657-RIPK1 when co-expressed, as did the TIR mutant P436H-TRIF-miniSOG (Fig. 5B) . Surprisingly, co-expression of tagRFP657-RIPK1 with DRHIM-TRIF-miniSOG seemed to shift some of the DRHIM-TRIF-miniSOG into punctae with tagRFP657-RIPK1, although elongated TRIF structures were still visible and did not colocalise with tagRFP657-RIPK1. This implies that when RIPK1 expression is high enough, it can also recruit DRHIM-TRIF potentially through bridging interactions with endogenous TRIF. The P436H DRHIM double mutant of TRIF also shows some punctate patterns when co-expressed with tagRFP657-RIPK1, although when expressed without RFP657-RIPK1 only cytosolic expression can be seen (Fig. 5A,B) .
To visualise the ultrastructure of these TRIF complexes, we used the activity of the miniSOG tag. Upon illumination of miniSOG in the presence of DAB, electron-dense material is deposited at sites corresponding to green fluorescence [36] . To confirm that this approach can reveal fibrils in a known fibrillar protein structure, RIPK3-miniSOG was also transiently transfected into HeLa cells and analysed by EM. RIPK3 forms punctate structures (similar to the ones shown here for TRIF) during necroptosis and when overexpressed [4] . When RIPK3 miniSOG was expressed in HeLas, punctate structures could also be detected by fluorescence microscopy (Fig. 6) . EM subsequently revealed these punctate structures to be fibrillar (Fig. 6) . RIPK3 is able to homo-and heterodimerise through its RHIM region. Importantly, when a DRHIM-RIPK3-miniSOG was expressed and resolved by EM, only amorphous, nonfibrillar staining could be seen supporting a role for RHIM interactions in forming RIPK3 fibrils and confirming the use of miniSOG tagging as a means to visualise fibrillar structures within cells (Fig. 6) .
Having confirmed that RIPK3-miniSOG forms detectable fibrils, the same experiments were performed for TRIF-miniSOG. Numerous clusters of electrondense material could be identified by EM in illuminated TRIF-miniSOG expressing HeLa cells (Fig. 7A) . These electron-dense clusters were revealed as fibrillar at higher magnifications (Fig. 7B-C) . The fibrils occur as loosely assembled strands and also as tightly bound bundles. Both the P436H and ΔRHIM mutants of TRIF also formed fibrillar structures, whereas the double mutant showed no detectable electron-dense staining of a similar nature indicating that both the TIR and RHIM regions are capable of assembling TRIF into fibrillar structures independently of each other (Fig. 7E-H) , although a contribution of endogenous TRIF in HeLa cells could not be ruled out. In addition, a number of TRIF-miniSOG-positive clusters were found to be engulfed in autophagosomes, again supporting TRIF as a target of autophagic degradation (Fig. 7D ).
Discussion
Here, we describe that the TLR3/TRIF/RIPK1/caspase-8 signalling complex involves the formation of TRIF-containing fibrils that have pro-apoptotic activity and are silenced by autophagy. TRIF was identified along with cleaved caspase-8, RIPK1 and RIPK3 in detergent-insoluble fractions and also in very large oligomers using SDD-AGE. Formation of large fibrillar signalling platforms is emerging as a common paradigm for signal transduction, particularly in immune signalling where a number of proteins have been identified to assemble into such structures. The model of fibrillary signalling platforms provides for an efficient method for signal amplification and threshold responses to regulate signal transduction [37] and such structures may be an important aspect of regulating TLR signalling via TRIF.
We believe that this is the first instance of a fibrillar signalling platform being viewed within the cell at this resolution. Although we had to use transfection of the constructs and the higher protein levels may facilitate fibril formation, the dependency on functional domains suggests specificity. Identification of the fibrils extends the previous observations where fibrils were detected largely using recombinant proteins.
The results presented here suggest that punctate structures that have been reported for TRIF, RIPK3 and RIPK1 are cognate with those detected using miniSOG tagging and consist of proteinaceous fibres. RIPK3 was shown to form amyloidal fibrils using largely in vitro reconstitution assays; however, immunoprecipitation of endogenous RIPK3 fibrils from cells triggered to undergo necroptosis could also be shown [4] . Such fibrils were much shorter and more linear in nature, unlike the large structures seen using miniSOG tagging; however, this may reflect the ability of immunoprecipitation to only isolate smaller, soluble fibrils, as well as reflect the level of expression in our experiments which may force larger than normal structures to form. Together these data suggest that formation of fibrillar complexes may indeed be a normal signalling mechanism for TRIF and perhaps other TIR containing proteins.
A consequence of fibril formation in signal transduction is that such large complexes must be efficiently disassembled. Interaction of RIPK1 and RIPK3 via RHIM-RHIM was shown to be extremely stable, even under highly denaturing conditions [4] , suggesting that disassembly of these fibres after signalling may not be a trivial task. We analysed autophagy as a potential mechanism for removal of TRIF containing complexes. At least some of the TRIF-miniSOG structures observed using EM appeared to be engulfed by autophagosomes. In melanoma cells, pI:C induced autophagy and induced interaction of TRIF with p62/ SQSTM1, which is indicative of TRIF being targeted by autophagy after TLR3 stimulation. TRIF was also shown to be directly degraded by autophagy in melanomas stimulated with pI:C. Autophagy inhibitors are under development as anti-cancer therapies [38] , and combination of these with IAP antagonism and TLR3 stimulation may prove a useful therapeutic approach. Interestingly, the kinetics of autophagy induction in melanoma cells matched well with the appearance of active caspase-8 supporting a potential co-regulation.
TRIF activation may lead to apoptosis and/or necroptosis; however, in all melanoma, cell lines tested only apoptosis could be detected. This failure to activate necroptosis is likely a result of a lack of detectable RIPK3 expression in all the melanoma cell lines tested. Two recent studies have reported this same observation for numerous cancers of different backgrounds [29, 30] . Those studies have shown that RIPK3 promoters may be methylated in cancer cells and expression could be restored by treatment with the hypo-methylating agent 5-AzaD. This may prove to be a useful approach in combination to restore sensitivity to TLR3 induced death both by apoptosis and necroptosis. RIPK3 is likely also to be targeted by autophagy of TRIF signalosomes, and it is tempting to speculate that autophagy inhibition may promote necroptotic death in response to TRIF activation, as it does for apoptotic signals.
We have shown that manipulating autophagy could be of therapeutic benefit in combination with IAP antagonism and TLR3 signalling by blocking turnover of TRIF containing fibrillar complexes. Little is known about the disassembly and removal of such complexes, and the finding that autophagy can help suppress TRIF signalling provides a new insight into how these platforms can be silenced after activation. An intriguing question is to what extent autophagy may be involved in turnover of other fibrillar signalling complexes and what implication this may have. These observations are likely to be applicable to signalling from TLR4 via TRIF and potentially other signalling platforms that form large fibrillar platforms and as such may have consequences for numerous signalling pathways in immunity. TLR3 and 4 are also expressed on cells such as macrophages, and the effects on inflammatory signalling induced by these cells in response to TLR stimulation should also be considered as blocking the silencing of TLR signalling by autophagy may also lead to unwanted or prolonged inflammatory signals.
Materials and methods

Cell lines and reagents
HeLa and MEF cell lines were grown in DMEM high glucose (Gibco, Life Technologies, Darmstadt, Germany) with 10% FCS (Gibco, Life Technologies), 1% (v/v) penicillin/ streptomycin (Gibco, Life Technologies). 1205LU, 451Lu, WM35, WM1158 and Sbcl2 human melanoma cells representing different stages of tumour progression [1205LU and 451Lu (from metastatic melanoma), and WM35 and Sbcl2 (radial-growth-phase melanomas) were obtained from M. Herlyn, Wistar Institute, Philadelphia, and cultured in TU2% melanoma medium containing 80% (v/v) MCDB153, Plasmids 39Flag-mmTRIF was cloned into pENTRSD/D-TOPO using the TOPO reaction and mutated using quickchange II mutagenesis kit (Agilent Technologies, Waldbronn, Germany). For mammalian expression 39Flag-mmTRIF was cloned either into pF5XUAS-GW-SV40-Puro-W (modified from pF5XUAS-MCS-SV40-Puro-W; a gift from J. Silke; WEHI, Melbourne, Australia) for Tamoxifen inducible expression or into the pFCMVTO-GW-miniSOG-SV40-Puro-W vector using gateway LR reactions (Life Technologies, Darmstadt, Germany). pFCMVTO-GW-miniSOG-SV40-Puro-W was created by cloning the ORF for miniSOG from pminiSOG-N1 (a gift from R. Tsien, UCSD) into pFCMVTO-GW-SV40-PURO-W. pFCMVTO-GW-SV40-PURO-W was created by cutting the promoter region of pF5XUAS-MCS-SV40-PURO-W [8] with PacI and NheI to remove the 59UAS. The CMV promoter and gateway cassette was amplified by PCR from the Invitrogen vector pLENTI4/TO/GW/V5/DEST and cloned into the PacI and NheI sites. Lentiviruses were made by transfecting the expression plasmids into HEK 293FT cells (Life Technologies) together with psPAX2 (a gift from Didier Trono; Addgene plasmid # 12260, Cambridge, MA, USA) and pMD2.G (a gift from Didier Trono; Addgene plasmid # 12259). The ATG5 shRNA construct was expressed from pLK0.1 and was a gift from H.-U. Simon (Bern, Switzerland). pFCMV-mCherry-GFP-LC3 was cloned into the pFCMVTO-GW-SV40-PURO-W using the gateway LR reaction. mCherry-GFP-LC3 was PCR amplified from pBABE-puro mCherry-EGFP-LC3B which was a gift from Jayanta Debnath (Addgene plasmid # 22418).
Cell death assays
Cell death was induced in MEFS by addition of LBW at 10 lM together with induction of TRIF using 100 lM 4HT for 24 h. Melanoma cells were pretreated with LBW 10 lM and/or LY 20 lM for 30 min prior to addition of pI:C (40 lgÁmL À1 for 1205LU and 451LU, and 1 or 10 ngÁmL
À1
for SBCL2, WM35 and WM1158) for 24 h. Cells were harvested by trypsinization and stained with propidium iodide (PI) before analysing by flow cytometry (BD Facs Calibur, BD, Heidelberg, Germany).
Combined fluorescence and electron microscopy
HeLa cells were seeded into glass coverslips in 12-well plates at 50 000 cells/well. The next day cells were transfected with 1 lg DNA/well at a ratio of 3 : 1 (Fugene:DNA). 24 h later, cells were fixed with 2% EM grade glutaraldehyde (Roth, Karlsruhe, Germany) in 0.1 M sodium cacodylate buffer pH 7.4 for 30 min. Cells were then rinsed three times with sodium cacodylate buffer, before incubating in blocking buffer (50 mM glycine, 10 mM KCN and 5 mM aminotriazole) to reduce nonspecific background reaction of diaminobenzidine (DAB). Cells were then washed once with sodium cacodylate buffer. Coverslips were placed cell side up into a small glass bottom dish and covered with a solution of 1 mgÁmL À1 DAB in 0.1 M sodium cacodylate buffer, pH 7.4, filtered through a 0.22 micron syringe filter (Millipore, Darmstadt, Germany). The region of interest is identified by miniSOG fluorescence using a FITC filter set and images of the fluorescence recorded with care not to bleach the area. A small tube attached to an oxygen tank is placed near the top of the dish, and a stream of pure oxygen was gently blown continuously over the top of the solution. The samples are then illuminated using a standard FITC filter set (EX470/40, DM510, BA520) illuminated with a 150W xenon lamp, using a 409 objective (NA 0.95). Illumination was stopped when brown reaction products corresponding to green fluorescence became visible using bright-field imaging. The cells were then removed from the microscope and washed in chilled buffer 29 to remove DAB. Samples were then prepared for EM as follows. Samples were contrasted using 1% OsO 4 (Roth) and 1% uranyl acetate (in 70% ethanol; Polysciences, Eppelheim, Germany). After dehydration, samples were embedded in durcupan (Sigma-Aldrich, Seelze, Germany). Ultrathin sections (40 nm) were analysed using a Zeiss LEO 906 transmission electron microscope (Jenna, Germany).
SDD-AGE
MEFs were seeded at 500 000 cells/well in a six-well plate and TRIF was either induced or not using 100 lM 4-Hydroxy Tamoxifen and treated as indicated for 15 h. Cells were then trypsinized and then washed with PBS. Cells were resuspended 50 lL of PBS containing 59 concentrated complete protease inhibitor cocktail (Roche, Mannheim, Germany), 10 lM ZVAD and 10 lM NEM. 50 lL of 1% SDS, 20 mM Tris.Cl pH 7.4 was added to lyse the cells and 1 lL of benzonase was added. Samples were left on ice for 10-15 min for benzonase to remove DNA. SDD-AGE loading dye was added to 19 concentration and then 80 lL of the lysate was loaded onto a 1.5% agarose gel (TAE, 0.1% SDS). The gel was run in 19 TAE, 0.1% SDS until dye front reached about 1 cm from the end of the gel. Proteins were transferred overnight at room temperature using capillary transfer as described in Halfmann and Lindquist [34] . Proteins were then detected using standard western blotting techniques. For detection of TRIF oligomers, membranes were first incubated for 30 min in denaturing buffer (6 M GuHCl, 100 mM NaCl, 20 mM Tris (pH 7.6), 0.5 mM EDTA, 10% glycerol, 0.1% Tween-20, 2% skim milk powder [39] ). Denaturing buffer was washed immediately using distilled water to discourage refolding of the proteins on the gel before following normal western blotting techniques.
Proximity ligation assay
Cells were seeded at 100 000 cells/well onto coverslips in 24-well plates. The next day cells were treated with pI:C for the indicated times and then washed 29 in PBS and fixed in 4% paraformaldehyde. Cells were then permeabilised and PLA reactions performed as per manufacturer's instructions using anti-TRIF (Cell Signaling #4596, NEB, Frankfurt am Main, Germany) 1 : 100 and anti-p62 (Abnova #H00008878-M01, BIOZOL, Eching, Germany) 1 : 500 in combination with Duolink in situ PLA probe anti-rabbit plus and Duolink in situ PLA probe anti-mouse minus in combination with Duolink in situ detection reagents orange. After Duolink reactions, cells were also stained with Hoechst. Images were acquired using a Keyence BZ-9000 microscope at 409 magnification taking Zstacks to detect all PLA signals within each cell. Z-stacks were merged into full focus images and number of cells automatically calculated by counting nuclei using ImageJ.
Numbers of PLA signals were also counted in ImageJ using the "find maxima" function. This was then converted into PLA signals per cell and results represented as relative PLA signals with untreated set as 1.
Active caspase-3 staining
Active caspase-3 staining for flow cytometry was performed with cells fixed for 20 min at room temperature in 4% PFA in PBS, washed in PBS containing 1% FCS, then lysed in PBS/1% FCS/0.5% saponin followed by incubation with rabbit anti-active caspase-3 antibody (Abcam, Cambridge, UK; 1 : 500) in staining buffer (PBS/1% FCS/0.5% saponin) for 30 min. Cells were washed three times with PBS/1% FCS and stained with Alexafluor 647-conjugated goat anti-rabbit IgG (1 : 300) (Dianova; 711-605-152, Hamburg, Germany) secondary antibody for 30 min. Cells were washed and analysed by flow cytometry.
